Showing results (31-40 of 79) with videos related to
Sort By:
Pageof 8
Journal of Neuropathology and Experimental Neurology|May 15, 2010
Neuropathologic and biochemical changes during disease progression in liver X receptor beta-/- mice, a model of adult neuron diseasePaolo Bigini, Knut R Steffensen, Anna Ferrario, et al.Clinical Sarcoma Research|August 31, 2017
Activity of anthracycline- and ifosfamide-based chemotherapy in a series of patients affected by advanced myxofibrosarcomaVittoria Colia, Marco Fiore, Salvatore Provenzano, et al.International Journal of Cancer|May 18, 2010
Imatinib response in two GIST patients carrying two hitherto functionally uncharacterized PDGFRA mutations: an imaging, biochemical and molecular modeling studyPalma Dileo, Sabrina Pricl, Elena Tamborini, et al.Cancers|April 3, 2021
Impact of Pathological Stratification on the Clinical Outcomes of Advanced Well-Differentiated/Dedifferentiated Liposarcoma Treated with TrabectedinChiara Fabbroni, Giovanni Fucà, Francesca Ligorio, et al.Translational Oncology|December 2, 2008
Is autophagy rather than apoptosis the regression driver in imatinib-treated gastrointestinal stromal tumors?Francesca Miselli, Tiziana Negri, Alessandro Gronchi, et al.Heliyon|April 10, 2024
Hemodialysis and imatinib: Plasma levels, efficacy and tolerability in a patient with metastatic GIST - Case reportIda De Luca, Daniela Miliziano, Giulia Guerra, et al.Clinical Sarcoma Research|September 3, 2020
Anthracycline-based and gemcitabine-based chemotherapy in the adjuvant setting for stage I uterine leiomyosarcoma: a retrospective analysis at two reference centersGiovanni Fucà, Chiara Fabbroni, Rosanna Mancari, et al.The Journal of Pharmacology and Experimental Therapeutics|May 3, 2008
Neuroprotective effects of the novel glutamate transporter inhibitor (-)-3-hydroxy-4,5,6,6a-tetrahydro-3aH-pyrrolo[3,4-d]-isoxazole-4-carboxylic acid, which preferentially inhibits reverse transport (glutamate release) compared with glutamate reuptakeSimona Colleoni, Anders A Jensen, Elisa Landucci, et al.Molecular Oncology|April 10, 2013
Are two better than one? A novel double-mutant KIT in GIST that responds to ImatinibElena Conca, Claudia Miranda, Valentina Dal Col, et al.Journal of Translational Medicine|September 28, 2011
Proteomic detection of a large amount of SCGFα in the stroma of GISTs after imatinib therapyLuca Da Riva, Fabio Bozzi, Piera Mondellini, et al.Pageof 8